1. The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls.
- Author
-
DeVito M, Bokkers B, van Duursen MBM, van Ede K, Feeley M, Antunes Fernandes Gáspár E, Haws L, Kennedy S, Peterson RE, Hoogenboom R, Nohara K, Petersen K, Rider C, Rose M, Safe S, Schrenk D, Wheeler MW, Wikoff DS, Zhao B, and van den Berg M
- Subjects
- Animals, Humans, Bayes Theorem, Dibenzofurans toxicity, Dibenzofurans, Polychlorinated toxicity, Mammals, World Health Organization, Dioxins toxicity, Polychlorinated Biphenyls toxicity, Polychlorinated Dibenzodioxins toxicity
- Abstract
In October 2022, the World Health Organization (WHO) convened an expert panel in Lisbon, Portugal in which the 2005 WHO TEFs for chlorinated dioxin-like compounds were reevaluated. In contrast to earlier panels that employed expert judgement and consensus-based assignment of TEF values, the present effort employed an update to the 2006 REP database, a consensus-based weighting scheme, a Bayesian dose response modeling and meta-analysis to derive "Best-Estimate" TEFs. The updated database contains almost double the number of datasets from the earlier version and includes metadata that informs the weighting scheme. The Bayesian analysis of this dataset results in an unbiased quantitative assessment of the congener-specific potencies with uncertainty estimates. The "Best-Estimate" TEF derived from the model was used to assign 2022 WHO-TEFs for almost all congeners and these values were not rounded to half-logs as was done previously. The exception was for the mono-ortho PCBs, for which the panel agreed to retain their 2005 WHO-TEFs due to limited and heterogenous data available for these compounds. Applying these new TEFs to a limited set of dioxin-like chemical concentrations measured in human milk and seafood indicates that the total toxic equivalents will tend to be lower than when using the 2005 TEFs., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: WHO has been working with EFSA in order to share the financial burden to update the TEF values for dioxin etc. The preparatory work done by KeyToxicology (KvE, EAFG) and ToxStrategies (LH, DW) including the update of the database was financed by EFSA. The selection of the invited experts was done solely by WHO and the costs for organizing the expert consultation was done by WHO funds. None of the WHO invited experts have indicated any conflicting interests in their WHO declarations of interests which were evaluated prior to the meeting., (Copyright © 2023. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF